Publications by authors named "Katja Rothfuss"

Claim this Profile
C
Clinical Characteristics and Treatment Strategies in a Cohort of Patients with Tularemia: A Retrospective Multicenter Analysis of 65 Cases in Germany.
Benjamin Arnold, Henning Trawinski, Nils Kellner, Hans-Martin Orth, Daniela Tominski, Katja Rothfuss

Antibiotics (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role and benefits of infectious diseases specialists in the COVID-19 pandemic: Multilevel analysis of care provision in German hospitals using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS) cohort.
Lene T Tscharntke, Norma Jung, Frank Hanses, Carolin E M Koll, Lisa Pilgram, Katja Rothfuss

Infection· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of High-Level Isolation Units in Response to High-Consequence and Emerging Infectious Diseases: Experience of the German STAKOB Network.
Michaela Niebank, Stefan O Brockmann, Torsten Feldt, Björn-Erik Ole Jensen, Annette Jurke, Katja Rothfuss

Health Secur· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumocystis jirovecii Pneumonia in Patients with Inflammatory Bowel Disease-a Case Series.
Sophie Vieujean, Annick Moens, Deborah Hassid, Katja Rothfuss, Edoardo Vincenzo Savarino

J Crohns Colitis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study.
Jan A Staessen, Ralph Wendt, Yu-Ling Yu, Sven Kalbitz, Lutgarde Thijs, Katja Rothfuss

Lancet Digit Health· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients.
Ralph Wendt, Lutgarde Thijs, Sven Kalbitz, Harald Mischak, Justyna Siwy, Katja Rothfuss

EClinicalMedicine· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interstitial and Granulomatous Lung Disease in Inflammatory Bowel Disease Patients.
Elena Eliadou, Joana Moleiro, Davide Giuseppe Ribaldone, Marco Astegiano, Katja Rothfuss

J Crohns Colitis· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extraintestinal manifestations and complications in inflammatory bowel diseases.
Katja S Rothfuss, Eduard F Stange, Klaus R Herrlinger

World J Gastroenterol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis